Compounds > carbostyril
Page last updated: 2024-08-17

carbostyril and Graft vs Host Disease

carbostyril has been researched along with Graft vs Host Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alfuraih, S; Barbarino, A; Shamloo, K; Sharma, A1
Fukui, M; Kamoi, M; Kawakita, T; Mukai, S; Ogawa, Y; Saijo-Ban, Y; Simmura, S; Tsubota, K; Yaguchi, S; Yamane, M1
Dürr, C; Finke, J; Fisch, P; Gerlach, U; Hechinger, AK; Hofmann, M; Leonhardt, F; Maas, K; Marks, R; Pircher, H; Prinz, G; Zeiser, R1

Other Studies

3 other study(ies) available for carbostyril and Graft vs Host Disease

ArticleYear
Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue.
    Investigative ophthalmology & visual science, 2019, 11-01, Volume: 60, Issue:14

    Topics: Administration, Ophthalmic; Alanine; Animals; Antioxidants; Bone Marrow Transplantation; CA-125 Antigen; Disease Models, Animal; Dry Eye Syndromes; Enzyme-Linked Immunosorbent Assay; Eye Proteins; Female; Goblet Cells; Graft vs Host Disease; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Mucin 5AC; Mucin-1; Mucin-4; Mucins; Periodic Acid-Schiff Reaction; Quinolones; Real-Time Polymerase Chain Reaction; Tears; Transplantation, Homologous

2019
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
    Optometry and vision science : official publication of the American Academy of Optometry, 2015, Volume: 92, Issue:4 Suppl 1

    Topics: Administration, Topical; Aged; Alanine; Drug Therapy, Combination; Dry Eye Syndromes; Enzyme Inhibitors; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Graft vs Host Disease; Humans; Middle Aged; Ophthalmic Solutions; Pemphigoid, Benign Mucous Membrane; Polyphosphates; Purinergic P2Y Receptor Agonists; Quinolones; Treatment Outcome; Uracil Nucleotides; Visual Acuity

2015
Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells.
    Haematologica, 2013, Volume: 98, Issue:1

    Topics: Animals; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; Graft vs Host Disease; Graft vs Leukemia Effect; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Prenylation; Protein Prenylation; Quinolones; Treatment Outcome

2013